TP53 and leukemia: For example, Mohapatra et al demonstrated that roscovitine preferentially induced apoptosis in prostate cancer and melanoma cells expressing wild-type P53 [43, 44], whereas in leukemia cells roscovitine-induced apoptosis resulted to be independent from the P53 status [45, 46].